In a filing, Quest Diagnostics, Inc revealed its SVP, Clinical Solutions KUPPUSAMY KARTHIK unloaded Company’s shares for reported $0.28 million on Oct 28 ’24. In the deal valued at $156.92 per share,1,775 shares were sold. As a result of this transaction, KUPPUSAMY KARTHIK now holds 9,734 shares worth roughly $1.5 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, KUPPUSAMY KARTHIK bought 1,775 shares, generating $278,450 in total proceeds.
Before that, PREVOZNIK MICHAEL E sold 32,551 shares. Quest Diagnostics, Inc shares valued at $5,044,516 were divested by the SVP & General Counsel at a price of $154.97 per share. As a result of the transaction, PREVOZNIK MICHAEL E now holds 38,478 shares, worth roughly $5.94 million.
Robert W. Baird upgraded its Quest Diagnostics, Inc [DGX] rating to an Outperform from a a Neutral in a research note published on October 23, 2024; the price target was increased to $182 from $157. Citigroup also remained covering DGX and has increased its forecast on July 10, 2024 with a “Buy” recommendation from previously “Neutral” rating. Leerink Partners started covering the stock on February 26, 2024. It rated DGX as “a Market perform”.
Price Performance Review of DGX
On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -0.62% to $154.33. Over the last five days, the stock has lost -1.02%. Quest Diagnostics, Inc shares have risen nearly 11.93% since the year began. Nevertheless, the stocks have risen 17.51% over the past one year. While a 52-week high of $160.95 was reached on 10/24/24, a 52-week low of $123.04 was recorded on 02/01/24. SMA at 50 days reached $153.41, while 200 days put it at $140.58.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 153.47, which if violated will result in even more drops to 152.62. On the upside, there is a resistance level at 155.71. A further resistance level may holdings at 157.10. The Relative Strength Index (RSI) on the 14-day chart is 52.88, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.90, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.15%. Stochastics %K at 56.32% indicates the stock is a holding.
How much short interest is there in Quest Diagnostics, Inc?
A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2024-10-15, dropping by 92630.0 shares to a total of 2.33 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.42 million shares. There was a decline of -3.98%, which implies that there is a negative sentiment for the stock.
